Oncology Product Launch

The Challenge

A global Life Sciences company was launching a new oncology drug in the US market and did not have a formal team and/or strategic launch plan in place one year prior to anticipated FDA approval.

This was the team’s first launch for the new drug, but many more were to follow as additional indications were anticipated to hit the market in the coming years.

The company – understanding that a launch comes with both excitement and complexity – approached Vynamic to help achieve two key objectives:

Our Approach

Vynamic guided the team through a 10-week ‘Boot Camp’ to ramp-up, kick-start and establish key program elements. Activities included:

After ‘Boot Camp’ Vynamic supported the team in launch plan execution by establishing accountability through efficient communication and transparency:

• Program monitoring and control;
• Risk identification and mitigation planning;
• Launch meeting management;
• Strategic oversight;
• Day 0 planning and execution.

The Results

Vynamic worked hand-in-hand with the launch team to:

1. Build repeatable processes and tools –
   not only for the initial launch but for multiple additional launches to date
2. Achieve Launch Readiness weeks before the PDUFA date
3. Execute flawlessly upon the Day 0 plan while setting new standards for the organization’s future launches

The client’s preparation enabled a successful launch into the market while creating rapid awareness and adoption of the drug – helping to maximizing its market share within the defined patient population.